First Allogeneic Cell Therapy Product Launched in Japan by Mesoblast Licensee
Feb 24, 2016 11:00 am UTC| Business
NEW YORK and MELBOURNE, Australia, Feb. 24, 2016 -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) announced that its licensee in Japan, JCR Pharmaceuticals Co. Ltd., today launched its mesenchymal stem cell product TEMCELL®...
MOL Global, Inc. Class Action Lawsuit Resolved
Feb 24, 2016 11:00 am UTC| Business
KUALA LUMPUR, Malaysia, Feb. 24, 2016 -- MOL Global, Inc. (Nasdaq:MOLG) ("MOL" or the "Company"), a leading e-payment enabler for online goods and services in emerging and developed markets, announced today an agreement...
Civeo Reports Fourth Quarter 2015 Results
Feb 24, 2016 11:00 am UTC| Business
HOUSTON, Feb. 24, 2016 -- Civeo Corporation (NYSE:CVEO) today reported financial and operating results for the fourth quarter ended December 31, 2015 as well as subsequent operational and financial updates. Highlights...
Memorial Production Partners LP Announces Fourth Quarter and Full-Year 2015 Results
Feb 24, 2016 11:00 am UTC| Business
HOUSTON, Feb. 24, 2016 -- Memorial Production Partners LP (NASDAQ:MEMP) announced today its operating and financial results for the three and twelve months ended December 31, 2015. Key Highlights: Average daily...
Feb 24, 2016 11:00 am UTC| Business
IRVINE, Calif., Feb. 24, 2016 -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that the first commercial...
Memorial Resource Development Corp. Announces Fourth Quarter and Full Year 2015 Results
Feb 24, 2016 11:00 am UTC| Business
HOUSTON, Feb. 24, 2016 -- Memorial Resource Development Corp. (Nasdaq:MRD) announced today its operating and financial results for the fourth quarter and year ended December 31, 2015. Financial highlights from fourth...
Mark Papazian, of Giarmarco, Mullins & Horton, P.C., Receives “AV” Peer Review Rating
Feb 24, 2016 11:00 am UTC| Business
TROY, Mich., Feb. 24, 2016 -- Mark Papazian has been awarded an “AV” Peer Review Rating from Martindale-Hubbell, the highest ranking by peers for ethical and legal ability. Mr. Papazian is a partner in Giarmarco,...